Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 

QPP Measure #481

Intravesical Bacillus-Calmette Guerin for Non-muscle Invasive Bladder Cancer

Percentage of patients initially diagnosed with non-muscle invasive bladder cancer and who received intravesical Bacillus-Calmette-Guerin (BCG) within 6 months of bladder cancer staging.

Submission Methods: Electronic Health Record
Measure Sets: Urology

There are no codes for this QPP measure.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.